west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "六合丹" 3 results
  • 中药六合丹外敷对混合痔外剥内扎术后水肿的效果评价

    目的观察六合丹外敷治疗混合痔术后对肛缘水肿的疗效。 方法将2013年5月-2014年1月收入的90例混合痔患者随机分为研究组和对照组,两组遵医嘱给予中药熏洗后,研究组予六合丹外敷治疗;对照组予马应龙麝香痔疮膏外敷治疗,观察两组患者用药后对肛缘水肿以及伤口疼痛的变化。 结果研究组用药后伤口疼痛评分和肛缘水肿评分均低于对照组,差异有统计学意义(P<0.05)。 结论六合丹外敷能有效改善混合痔术后肛缘水肿和局部疼痛,具有临床意义,值得临床推广。

    Release date: Export PDF Favorites Scan
  • 外用六合丹湿敷治疗急性嵌顿痔水肿的疗效观察

    目的观察传统中药方剂六合丹治疗急性嵌顿痔水肿的临床疗效。 方法收集四川大学华西医院中西医结合科2013 年2 月- 2014 年2 月收治符合纳入标准的急性嵌顿痔患者82 例,将其随机分为治疗组(n=40)与对照组(n=42)。治疗组用六合丹湿敷,对照组予以硫酸镁湿敷,观察两组嵌顿痔患者在痔水肿评分、疼痛口述评分等指标的差异。 结果治疗后治疗组相比于对照组,在痔水肿评分及疼痛口述评分的改善方面差异均有统计学意义(P < 0.05)。 结论六合丹应用于急性嵌顿痔水肿的治疗,能收到较好的疗效,为其进一步手术治疗创造良好条件,传统中药方剂六合丹具有较高的临床应用价值。

    Release date: Export PDF Favorites Scan
  • The impact of Liuhedan on interleukin-1β and tumor necrosis factor-alpha during infective wound healing in rabbits

    Objective To explore the mechanism of Liuhedan in promoting wound healing through applying Liuhedan to the infective wounds of New Zealand white rabbits. Methods A total of forty New Zealand white rabbit models of infective wounds were established after anesthesia. Five circular infective incisions were generated on the back of each rabbit, with a diameter of 2 cm. Five wounds of each rabbit were assigned respectively to the control group, model group, traditional Chinese medicine (TCM) group (Oleum Lithospermum), Western medicine group (calcium alginat), and treatment group (Liuhedan). Wound dressings were performed every day since postoperative day 1. Ten rabbits were selected randomly to be euthanized on postoperative day 3, 7, 14 and 21, respectively. Each specimen was divided into two parts. One was used for detecting interleukin-1β (IL-1β) by enzyme-linked immunosorbent assay, and the other was used for detecting tumor necrosis factor-α (TNF-α) by immunocytochemistry. Results On postoperative day 3 and 7, groups with the expression of IL-1β from low to high were respectively the control group, the treatment group, the Western medicine group, the TCM group, and the model group [postoperative day 3: (680.81±185.53), (1 028.67±205.57), (1 278.67±251.15), (1 449.86±230.74), (1 544.62±371.77) pg/mL; postoperative day 7: (1 024.43±239.94), (1 333.57±257.31), (1 635.14±222.40), (1 784.71±323.85), (1 953.29±324.78) pg/mL], and all the differences among the groups were significant (P<0.05); On postoperative day 14, groups with the expression of IL-1β from low to high were respectively the treatment group, the control group, the Western medicine group, the TCM group, and the model group [(908.71±108.61), (978.57±161.75), (1 120.43±265.39), (1 129.71±298.06), (1 191.14±234.92) pg/mL], and all the differences among groups were significant (P<0.05) except the difference between the Western medicine group and the TCM group (P>0.05); On postoperative day 21, the expression of IL-1β in the control group, the model group, the TCM group, and the Western medicine group was (487.19±121.80), (496.35±102.15), (500.31±139.34), (499.08±120.67) pg/mL, respectively, with no significant differences among the groups (P>0.05), which were all higher than that in the treatment group [(398.62±102.93) pg/mL] with significant difference (P<0.05). The expression of TNF-α in the model group was significantly greater than those in the other groups. The expression of TNF-α in the treatment group and Western medicine group was significantly lower compared with the model group. The expression of TNF-α in the TCM group was stronger compared with those in the treatment group and the Western medicine group. Conclusion Liuhedan can specifically suppress the expressions of IL-1β and TNF-α in the treatment of infective wounds, decrease the release of inflammatory factor and promote the healing.

    Release date:2017-10-27 11:09 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content